Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs

EXPERT OPINION ON EMERGING DRUGS · Published 2026-07-17 · DOI 10.1080/14728214.2026.2706609

Authors (5)

Sarah Ottum, Namrata Sethi, Cem Demirkiran, Orazio De Tommasi, Alessandro D. Santin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ottum, S., Sethi, N., Demirkiran, C., et al. (2026). Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs. EXPERT OPINION ON EMERGING DRUGS. https://doi.org/10.1080/14728214.2026.2706609

Related articles